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Abstract 10 
In the present work, internal standardization based on species-unspecific isotope dilution 11 
analysis technique is proposed in order to overcome the matrix effects and signal drift originated in 12 
the speciation of As in urine by HPLC-ICP-MS. To this end, 72Ge has been selected as a pseudo-13 
isotope of As. The resulting mass flow chromatogram of the element allows the calculation of the 14 
corrected overall species concentrations without requiring any methodological calibration, 15 
providing high-throughput sample processing. The validation was carried out by analyzing a blank 16 
human urine fortified at three concentration levels and an unspiked human urine sample containing 17 
different species of arsenic. In all cases, recoveries ranging from 90 to 115% and RSD below 10% 18 
were attained with this approach. Furthermore, the proposed method provided results in excellent 19 
agreement with those obtained using standard additions and internal standard calibration, allowing a 20 
fast way to assess human exposure to arsenic species. 21 
1. Introduction 22 
It is widely known that potential health risk to arsenic exposition depends on the chemical form 23 
entering the human body, due to the different degree of toxicity of these compounds.1-4 Urine is 24 
regarded as an important biomarker of arsenic intake. In this regard, a speciation analysis of urine is 25 
usually performed by HPLC-ICP-MS.5-10 However, signal drift and matrix effects are observed due 26 
to urine matrix, hampering the quantification of such species.11 27 
The use of species-unspecific isotope dilution analysis allows the correction for those errors, 28 
providing accurate and precise determinations of the sought element. In the case of arsenic, there is 29 
only one isotope available to be measured (m/z 75); therefore, an internal standard of an element 30 
close to the analyte mass has to be selected to follow the isotope dilution procedure.12 This 31 
approach, which we have called “pseudo-unspecific isotope dilution analysis”, could make possible 32 
to obtain the accurate concentrations of the above mentioned species in a single run. 33 
The developed method was applied for the analysis of human urine samples fortified at different 34 
concentration levels and compared with internal calibration and the standard additions method.35 
2. Experimental 36 
2.1. Instrumentation 37 
The HPLC system consisted of an Agilent 1100 Series (Agilent, Waldbronn, Germany) 38 
binary pump and auto injector with a programmable sample loop (100 µL maximum). The 39 
separations were performed on a PRP-X100 (Hamilton, Reno, NV, USA) anion-exchange 40 
column (250 x 4.1 mm, 10 µm). An additional Agilent 1100 Series binary pump was used to 41 
continuously add the internal standard solution. 42 
The outlet of the chromatographic column was connected through a T piece to a Meinhard 43 
concentric nebulizer. An Agilent 7500cx inductively coupled plasma mass spectrometer 44 
(Agilent Technologies, Tokyo, Japan) equipped with an octopole reaction cell using helium as 45 
a reaction gas to reduce polyatomic interferences on arsenic was used in this work. For 46 
HPLC-ICP-MS data acquisition, the “time resolved analysis” mode was used with 1 second of 47 
integration time per mass.  48 
For tuning of ICP-MS, a solution containing 10 µg L-1 of As made up in double deionized 49 
water filtered through 0.45 µm was monitored at m/z 75 and 72; the ion intensity, resolution 50 
and mass axis were optimized. 51 
2.2. Standards and reagents 52 
Arsenite (AsIII), arsenate (AsV), dimethylarsinic acid (DMA) and arsenobetaine form (AsB) 53 
were delivered by Fluka (Buchs, Switzerland), while monomethylarsonic acid (MMA) was 54 
from Carlo Erba (Milano, Italy). The stock solutions of  arsenic species containing about 1000 55 
mg L-1 of As were prepared in water and maintained at 4 ºC after standardization against an 56 
atomic absorption arsenic standard solution (J.T. Baker, Phillipsburg, USA).13 Appropriate 57 
dilutions of the stock solution were prepared daily, by weight, using double deionized water 58 
to obtain the required concentration. Germanium internal standard and nitric acid was 59 
purchased from Fluka. 60 
A previously developed method5 based on HPLC-ICP-MS coupling system was optimized 61 
in order to separate the five arsenic species in human urine. The mobile phase consisted of 4 62 
mM ammonium phosphate (Merk, Darmstad, Germany), 4 mM ammonium hydrogen 63 
carbonate (Fluka) and 4 mM ammonium sulfate (Sigma, St. Louis, MO, USA). The pH value 64 
was adjusted to 8.9 by the addition of ammonium hydroxide (Trace Select, Fluka). These 65 
solutions were filtered through a 0.45 µm membrane before use. 66 
All the aqueous solutions were prepared with Milli Q Gradient A10 (Millipore, Molsheim, 67 
France) water (18.2 MΩ cm). 68 
2.3. Analytical procedure 69 
Urine samples were diluted 5 fold with 0.1 % nitric acid before injection. The flow coming 70 
from the column (0.95 mL min-1) was mixed with the internal standard solution containing 71 
around 15 ng g-1 of Ge and 4 ng g-1 of As (0.15 mL min-1). The signals for m/z 75 and 72 72 
were monitored over time. After smoothing of the data using moving average (n = 5) in order 73 
to reduce noise level the isotope ratio 75As/72Ge was calculated. Then, the on-line pseudo-74 
isotope dilution equation was applied to each point of the chromatogram to obtain the mass 75 
flow chromatogram. The amount of arsenic in each fraction was determined by integration of 76 
the chromatographic peaks using the Origin 5.0 software (Microcal Software Inc., 77 
Northampton, MA, USA). Finally, the concentration of arsenic was computed by dividing the 78 
As amount found by the injection volume. 79 
3. Results and discussion 80 
3.1. Selection of internal standard and development of the equation for on-line pseudo-isotope 81 
dilution analysis 82 
In order to appropriately correct for matrix-induced signal enhancement or suppression as 83 
well as for drift instability of the instrument, the analyte and the internal standard should 84 
undergo an equal relative signal intensity drift. To this end, mass-to-charge ratio and 85 
ionization potential of both elements should be as close as possible, being especially critical 86 
the first factor. In this regard, selenium seems the best candidate to use as internal standard for 87 
arsenic speciation.12,14 However, this element is often present in urine samples, which can 88 
produce errors in the normalization. By contrast, germanium is rarely present in urine samples 89 
and has been satisfactory used for matrix effects correction.15 As a consequence, the isotope 90 
72Ge was selected as internal standard.  91 
The proposed procedure is based on post-column isotope dilution analysis.16 Briefly, this 92 
technique consists in the on-line addition of an isotopically enriched solution of the sought 93 
element after the chromatography separation to modify the original isotope abundances in the 94 
sample. The resulting isotope ratio (in the mixture) of the most abundance isotope in the 95 
sample and the spike permits to calculate the endogenous concentration contained in each 96 
chromatographic peak. In the case of arsenic, a germanium internal standard is used instead of 97 
a spike, owing to its monoisotopic character. Since both elements have different ionization 98 
efficiencies, the experimental isotope ratio in the mixture Rm (
75As/72Ge) will not provide the 99 
As/Ge molar ratio. The instrumental response of Ge present in the mixture must be previously 100 
normalized to As in order to correlate Rm with the analyte concentration. For this purpose, a 101 
known amount of As was added within the internal standard solution and the corresponding 102 
isotope ratio RIS (
75As/72Ge) was measured. Consequently, Rm and RIS can be expressed as 103 
follows:  104 
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were AssN  (mol g
-1) shows the amount of As in the sample with density ds (g mL
-1) pumped at 107 
a flow rate fs (mL min
-1), which is mixed with AsISN  (mol g
-1) of As arising from the internal 108 
standard solution pumped at a flow rate fIS (mL min
-1) and density dIS (g mL
-1). The term 109 
'Ge
ISN (mol g
-1) is the concentration of Ge normalized to As, which must not be confused with 110 
the true amount of Ge. Indeed, 'GeISN  would represent the mol g
-1 of 72Ge contained in the 111 
internal standard solution if the ionization efficiency were the same as As. When we combine 112 
eqns. (1) and (2) the following expression is obtained:  113 
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Please note that the true amount of Ge is not needed in the calculation. Rearranging eqn. 115 
(3) for AssN , we obtain: 116 
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Concentrations in mol g-1 can be expressed as concentrations in weight by taking into 118 
account the atomic weight of the element. Since the atomic weight of As in the sample 119 
( AssAW ) and in the internal standard solution (
As
ISAW ) are the same, eqn. (4) becomes: 120 
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were AssC  and 
As
ISC  are the mass concentrations (ng g
-1) of As in the sample and internal 122 
standard solution, respectively. ss
As
s fdC ⋅⋅  has the units of ng min
-1 and it is the mass flow of 123 
the sample eluting from the column, MFs. Then, the final pseudo-isotope dilution equation has 124 
the form: 125 
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If the analyte concentration changes with time, e.g., during the chromatographic peak, MFs 127 
will also change with time. The integration of the chromatographic peak in the mass flow 128 
chromatogram will give the amount of As in that fraction. The concentration is then easily 129 
calculated knowing the sample volume injected. Eqn. (6) was thus used for calculations in the 130 
present work.  131 
3.2. Analytical results 132 
In a preliminary study, the concentration of the As primary standard in the internal 133 
standard solution was optimized. On the one hand, it has to be taken into account that a high 134 
enough amount of exogenous As is required to minimize the m/z 75 background influence. 135 
On the other hand, the higher amount of 75As coming from the post-column solution the 136 
higher baseline noise, leading to poorer detection limits of the endogenous species. Thereby, a 137 
concentration of ca. 4 ng g-1 was selected as a compromise. The case of Ge internal standard 138 
concentration is much less critical because it does not contribute to the signal of the analyte 139 
eluting from the column and does not influence the final results. In addition, the 140 
chromatographic and post-column flow rates were tested. The final values used for the mobile 141 
phase and the internal standard solution (0.95 and 0.15 mL min-1, respectively) allowed the 142 
elution of all the species in a proper time without sacrificing the accuracy of the post-column 143 
flow rate. 144 
To a better understanding of the procedure, Fig. 1 illustrates the conversion from original 145 
ICP-MS intensities to mass flow. The chromatograms corresponding to m/z 75 and 72 (a) are 146 
first transformed into the isotope ratio chromatogram (b). It is worth stressing that 75As and 147 
72Ge background signal from mobile phase was negligible (data not shown), thus the baseline 148 
of the isotope ratio chromatogram provides RIS (see Fig. 1b). Next, equation (6) is applied to 149 
the whole chromatogram. Finally, the mass flow peaks of Fig. 1c are integrated and divided 150 
by the injection volume (50 µL). It should be remarked that the present strategy permits to 151 
correct for errors derived from instrumental instabilities and matrix effects in the whole 152 
chromatogram, since the Ge internal standard is continuously added to the effluent from the 153 
column. 154 
The proposed procedure was applied to the analysis of a blank urine sample  spiked at 1, 5 155 
and 10 µg As L-1 (concentrations referred to the diluted urine injected). It is worth noting that 156 
the blank urine used corresponds to an unexposed human and no As species were found when 157 
it was analyzed by the conventional calibration method. Ten replicates for each of the three 158 
fortification levels were carried out. Additionally, in order to check the suitability of 72Ge as 159 
internal standard the results were compared with those obtained using internal standard 160 
calibration. To this end, calibration standards containing 0-20 µg L-1 of As for each compound 161 
were injected by triplicate within the post-column solution. Then, the isotope ratio 162 
chromatogram was plotted (as exemplify in Fig. 1b). Satisfactory recoveries, between 90 to 163 
105%, were obtained both for the medium and highest fortification levels when pseudo-164 
unspecific IDA was used. At the lowest fortification level, which was closed to the detection 165 
limit, recoveries were in the range of 96-115% and coefficients of variation were below 10% 166 
(Table 1). No significant differences were noticed between both methods, thus it seems that 167 
calibration-free measurements based on eqn. (6) can be performed for the quantification of As 168 
species in urine. 169 
Intermediate precision (n = 9) was also estimated by analyzing replicates of the medium 170 
fortification level on 3 different days. The coefficient of variation was found to be <8% in all 171 
cases. Detection limits, defined as three times the signal-to-noise ratio in the mass flow 172 
chromatogram were determined for the blank urine sample spiked at 1 µg L-1 of each As 173 
species. As can be seen in Table 1, LODs were <0.7 µg L-1 in the diluted urine. In fact, the 174 
continuous addition of arsenic post-column to normalize de germanium response increase 175 
notably the detection limits. However, these values are satisfactory to evaluate the potential 176 
risk of people exposed to inorganic arsenic. Actually, the American Conference of 177 
Governmental Industrial Hygienists (ACGIH) and Deutsche Forschungsgemeinschaft (DFG) 178 
set the BEI and BAT values for occupational arsenic exposure as 35 µg As L-1 and 50 µg L-1, 179 
using the sum of inorganic arsenic, MMA and DMA.17 180 
The validity of the proposed method for correcting instrument signal drift was tested with 181 
the injection of a 15-h batch run. Fig. 2a compares the intensity chromatograms 182 
corresponding to the first and last injections of the experiment. Appreciable signal drift was 183 
observed between them, resulting in lower peak areas for the second injection. The 184 
application of eqn. (6) lead to the mass flow chromatograms presented in Fig. 2b. As 185 
expected, no significant differences were noticed between injections, which confirm that 186 
appropriate correction of signal drift is achieved. It is worth mentioning the severe signal 187 
suppression at the dead volume caused by the high salt content of urine sample (Fig. 2a). In 188 
this case, instrumental instability was not totally overcame (Fig. 2b), most probably because 189 
the Ge internal standard suffers more signal depression than As in the presence of high 190 
concentration of Na. Anyway, such anomalous behavior does not affect any chromatographic 191 
peak 192 
Finally, the quantification of a human urine sample containing different species of arsenic 193 
was performed by the present methodology, internal standard calibration and standard 194 
additions (Table 2). The concentrations calculated by pseudo-unspecific IDA were in very 195 
good agreement with those obtained using the other quantification strategies. These data 196 
confirm the suitability of the developed procedure for arsenic speciation studies in human 197 
urine. 198 
Conclusions 199 
A new procedure for the simultaneous determination of AsB, AsIII, AsV, DMA and MMA 200 
in human urine which does not require any methodological calibration graph and allows 201 
correcting for instrumental instabilities has been developed. For this purpose, species 202 
unspecific isotope dilution analysis has been adapted to As using 72Ge as an additional isotope 203 
of the sought element.  204 
The proposed method has been successfully validated in spiked and unspiked human 205 
urinesamples. In addition, the results were in excellent agreement with internal standard 206 
calibration and standard additions. 207 
The need for addition a known amount of As to normalized the Ge concentration increases 208 
appreciably the LODs. This fact however, do not hampers the correct quantification of toxic 209 
inorganic species of arsenic in urine of exposed humans 210 
Therefore, the possibility to carry out the quantification of As species in a single run 211 
provided by the developed procedure could be very useful to assess workplace, drinking water 212 
or food exposure to inorganic arsenic. 213 
Acknowledgements 214 
Fundació Caixa Castelló-Bancaixa is acknowledged for the financial support provided to 215 
Àngel Castillo and for the project P1-1B2009-29. ICP-MS measurements were made at the 216 
Servei Central d’Instrumentació Científica (SCIC), Universitat Jaume I. 217 
We would like to thank Dr J. Ignacio García Alonso for their useful comments and help. 218 
The authors acknowledge the financial support of Generalitat Valenciana, as research 219 
group of excellence PROMETEO/2009/054. 220 
 221 
References 222 
[1] K. T. Suzuki, B. K. Mandal and Y. Orga, Talanta, 2002, 58, 111. 223 
[2] I. Pizarro, M. Gómez, C. Cámara and M. A. Palacios, Analytical Chim. Acta., 2003, 495, 85. 224 
[3] B. K. Mandal, Y. Orga, K. Anzai and K. T. Suzuki, Toxicol. Appl. Pharmacol., 2004, 198, 307. 225 
[4] S. Rabieh, A. V. Hirner and J. Matschullat, J. Anal. At. Spectrom., 2008, 23, 544. 226 
[5] T. I. Todorov, J. W. Ejnik, F. G. Mullick and J. A. Centeno, Microchim Acta, 2005, 151, 263. 227 
[6] R. Xie, W. Johnson, S. Spayd, G. S. Hall and B. Buckley, Anal. Chim. Acta, 2006, 578, 186. 228 
[7] E. I. Brima, R. O. Jenkins, P. R. Lythgoe, A. G. Gault, D. A. Polya and P. I. Haris, J. Environ. 229 
Monit., 2007, 9, 98. 230 
[8] W. C. Davis, R. Zeisler, J. Sieber and L. L. Yu, Anal. Bioanal. Chem., 2010, 396, 3041. 231 
[9] P. Bélanger and P. Dumas, Atom. Spectrosc., 2010, 31, 175. 232 
[10] J. Morton and E. Leese, Anal. Bioanal. Chem., 2011, 399, 1781. 233 
[11] C. P. Verdon, K. L. Caldwell, M. R. Fresquez and R. L. Jones, Anal. Bioanal. Chem., 2009, 393, 234 
939. 235 
[12] C. J. Park and H. Song, J. Anal. At. Spectrom., 2005, 20, 436. 236 
[13] R. Wahlen and G. Woods, Agilent ICP-MS Journal, May 2011, 46, 4. 237 
[14] P. Serapinas, G. Labarraque, P. Charlet, Z. Ezerinskis and V. Juzikiene, J. Anal. At. Spectrom., 238 
2010, 25, 624. 239 
[15] I. B. Rodriguez, K. A. Francesconi and W. Groessler, J. Anal. At. Spectrom., 2008, 23, 235. 240 
[16] P. Rodriguez-González, J. M. Marchante-Gayón, J. I. García Alonso and A. Sanz-Medel, 241 
Spectrochim. Acta Part B, 2005, 60, 151. 242 
[17] A. Hata, Y. Endo, Y. Nakajima, M. Ikebe, M. Ogawa, N. Fujitani and G. Endo, J Occup Health, 243 
2007, 49, 217.244 
Table 1. Analytical characteristics of the pseudo-unspecific IDA procedure obtained for a blank urine sample fortified at three different levels. 
 1 µg As L-1 5 µg As L-1 10 µg As L-1 
Species Pseudo-IDA ICb 
Pseudo-
IDA 
IC 
Pseudo-
IDA 
IC 
Intermediate 
precision. 5 µg As L-
1 C.V. (%) (n=9) 
LODc   
(µg L-1) 
AsB 96.8 (8.7)a 104.6 (10.0) 90.8 (1.8) 99.4 (1.5) 92.1 (2.2) 101.3 (0.9) 6.2 0.3 
AsIII 99.5 (5.9) 111.0 (4.0) 100.7 (7.4) 106.5 (5.1) 
101.1 
(4.9) 
104.8 (0.9) 7.4 0.6 
DMA 102.0 (6.3) 106.5 (3.5) 97.5 (9.5) 94.3 (6.9) 
100.0 
(2.3) 
94.4 (1.6) 3.5 0.3 
MMA 114.6 (1.7) 115.6 (2.4) 101.1 (9.2) 101.8 (6.8) 
102.6 
(3.0) 
101.6 (3.3) 5.5 0.4 
AsV 104.0 (3.6) 104.2 (5.4) 95.7 (6.6) 103.1 (6.8) 96.5 (1.1) 103.1 (0.4) 3.8 0.7 
a The uncertainty in the values corresponds to 1 s standard deviation of 10 independent HPLC-ICP-MS injections. 
b Recoveries calculated using internal standard calibration, for comparison. 
c Detection limits referred to diluted urine sample. 
Table 2. Comparison of different methodologies to correct for matrix effects in the analysis of a human urine sample. 
Method AsB, µg L-1 AsIII, µg L-1 DMA, µg L-1 MMA, µg L-1 AsV, µg L-1 
Sum of the 
species 
Pseudo-unspecific IDA 15.5 ± 0.3 ND 3.2 ± 0.2 2.5 ± 0.5 3.8 ± 0.3 25.0 ± 1.3 
Internal standard 
calibration 
16.4 ± 0.3 ND 3.4 ± 0.2 
2.1 ± 0.5 4.0 ± 0.5 25.9 ± 1.5 
Standard additions 14.6 ± 0.1 ND 3.0 ± 0.1 2.4 ± 0.1 3.5 ± 0.1 23.5 ± 0.4 
 
Figure captions 
Figure 1.- Conversion process from intensities to mass flow using the pseudo-isotope dilution 
equation. 
Figure 2.- Use of Ge as a pseudo-isotope of As to correct for instrumental signal drift observed 
during a 15-h batch run. 
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a) Intensity chromatograms
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